From: Survival of cancer patients with pre-existing heart disease
Characteristic | Number of patients (% with heart disease prior to diagnosis) | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
All cancer (ex NMSC) | Colorectal cancer | Lung cancer | Female breast cancer | Prostate cancer | ||||||
Gender | ||||||||||
All patients | 34,828 | 22.6% | 4,656 | 25.3% | 4,748 | 32.3% | 4,992 | 10.4% | 4,232 | 22.6% |
Male | 17,449 | 27.1% | 2,572 | 27.1% | 2,635 | 35.6% | - | - | 4,232 | 22.6% |
Female | 17,379 | 18.2% | 2,084 | 23.0% | 2,113 | 28.2% | 4,992 | 10.4% | - | - |
Age group | ||||||||||
0-54 | 6,500 | 3.6% | 560 | 3.9% | 341 | 8.8% | 1,628 | 1.9% | 224 | 5.8% |
55-69 | 10,812 | 14.3% | 1,417 | 13.2% | 1,510 | 22.7% | 1,647 | 6.0% | 1,733 | 13.6% |
70-79 | 10,541 | 29.1% | 1,575 | 29.8% | 1,893 | 36.2% | 1,016 | 16.1% | 1,543 | 25.9% |
80+ | 6,975 | 43.6% | 1,104 | 45.1% | 1,004 | 47.1% | 701 | 32.0% | 732 | 42.3% |
Deprivation | ||||||||||
Least deprived (Quintile 1) | 6,792 | 20.3% | 918 | 24.1% | 646 | 33.4% | 1,088 | 9.0% | 934 | 19.7% |
Quintile 2 | 7,038 | 23.3% | 987 | 27.4% | 815 | 32.8% | 1,086 | 9.4% | 929 | 23.8% |
Quintile 3 | 7,060 | 23.9% | 961 | 26.8% | 931 | 37.5% | 993 | 11.2% | 886 | 23.4% |
Quintile 4 | 7,215 | 24.1% | 927 | 26.1% | 1,005 | 34.0% | 1,007 | 11.6% | 864 | 24.3% |
Most deprived (Quintile 5) | 6,719 | 21.3% | 862 | 21.6% | 1,351 | 26.5% | 818 | 10.9% | 619 | 22.0% |
Unknown | 4 | - | 1 | - | 0 | - | 0 | - | 0 | - |
Stage | ||||||||||
Stage I/II | 14,516 | 17.3% | 1,964 | 25.3% | 997 | 34.3% | 3,633 | 7.9% | 2,344 | 19.2% |
Stage III | 5,382 | 20.0% | 1,200 | 21.4% | 1,030 | 29.8% | 668 | 8.8% | 729 | 18.5% |
Stage IV | 6,816 | 24.2% | 936 | 20.6% | 2,072 | 28.8% | 290 | 11.4% | 699 | 27.2% |
Unknown | 8,114 | 32.5% | 556 | 41.4% | 649 | 44.1% | 401 | 34.7% | 460 | 40.0% |
Comorbidity | ||||||||||
Previous cancer | 1,686 | 28.1% | 287 | 31.0% | 300 | 33.7% | 218 | 16.1% | 133 | 30.8% |
Cerebrovascular disease | 1,260 | 72.2% | 157 | 69.4% | 262 | 76.0% | 87 | 69.0% | 145 | 69.7% |
Chronic pulmonary disease | 4,200 | 47.0% | 494 | 43.3% | 1,393 | 50.6% | 244 | 38.5% | 376 | 49.5% |
Hypertension | 8,940 | 48.8% | 1,500 | 45.7% | 1,444 | 57.1% | 658 | 43.5% | 1,021 | 48.4% |
Diabetes | 3,388 | 48.9% | 564 | 47.2% | 535 | 58.9% | 216 | 40.3% | 334 | 46.4% |
Liver disease | 531 | 37.5% | 68 | 42.6% | 75 | 32.0% | 24 | 16.7% | 15 | 53.3% |
Renal disease | 1,965 | 62.7% | 303 | 64.7% | 329 | 66.6% | 87 | 62.1% | 183 | 60.7% |
Peptic ulcer | 709 | 43.0% | 110 | 40.9% | 102 | 52.0% | 32 | 21.9% | 49 | 61.2% |
Anaemia | 1,373 | 46.9% | 476 | 42.9% | 161 | 59.0% | 77 | 44.2% | 58 | 60.3% |
Neurodegenerative disorders | 1,568 | 47.3% | 199 | 53.3% | 262 | 48.1% | 123 | 40.7% | 135 | 49.6% |
Rheumatic disorders | 574 | 50.3% | 66 | 45.5% | 124 | 49.2% | 43 | 60.5% | 41 | 51.2% |